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1,595 patients received DES. Patients were assigned to four groups according to the
quadrant values of admission HbA1c. The primary endpoint was composite of MACE
(all-cause death, ACS and revascularization). The mean follow-up duration was 4.5
years. As ﬁgured showed, the higher the HbA1c, the higher the rate of MACE and ASC
plus death (p<.0001, 0.002) in the BMS group. However, HbA1c showed no such
correlation with MACE and ACS plus death (p ¼ 0.20, 0.69) in the DES group. Multi-
variable Cox regression analysis showed that HbA1c was not associated with long-
term outcomes in DES.
CONCLUSIONS HbA1c has no impact on long-term outcomes of patients implanted
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BACKGROUND Drug-eluting balloons (DEB) have shown effectiveness in the treat-
ment of bare metal and drug-eluting stent in-stent restenosis (ISR). Preclinical in-
vestigations have suggested that coating technology is crucial for the efﬁcacy of DEB.
Aim of this study is to compare the antirestenotic efﬁcacy of two paclitaxel DEB with
different coatings in the treatment of ISR by means of a morphological and functional
assessment.
METHODS In a single center, prospective, non-randomized study, the shellac-pacli-
taxel coated DIOR (EuroCor GmbH, Bonn, Germany) and the urea-paclitaxel coated
IN.PACT Falcon (Medtronic Vascular Inc., Santa Rosa, CA, USA) were compared in the
setting of ISR. Besides quantitative angiography, fractional ﬂow reserve (FFR) and
optical coherence tomography (OCT) were performed at baseline, post-procedure and
6-months follow-up. Main endpoints of the analysis were QCA, FFR and OCT-based
parameters of restenosis.
RESULTS Forty-ﬁve patients were included, 20 (44%) received treatment with the
DIOR and 25 (56%) with the IN.PACT Falcon. Angiographic and device success were
100% and 90% for the DIOR, and 100% and 92% for the IN.PACT Falcon, respec-
tively. At 6-months follow-up, in-segment late lumen loss (-0.030.43 vs.
0.360.48 mm, p¼0.014) and diameter stenosis (30.716.2 vs. 41.322.6%, p¼0.083)
were lower for the IN.PACT Falcon. FFR distal of the stent was signiﬁcantly higher
in the IN.PACT Falcon group (0.920.07 vs. 0.840.13, p¼0.029) and in-stent FFR
gradient was lower (0.050.05 vs. 0.130.12, p¼0.002). Between postprocedure and
follow-up, a 16% decrease in neointimal volume was observed for the IN.PACT
Falcon, while a 30% increase was observed for the DIOR (p¼0.006). Target lesion
revascularization rate was 8% in the IN.PACT Falcon and 30% in the DIOR group
(p¼0.11).
CONCLUSIONS The IN.PACT Falcon DEB showed higher antirestenotic efﬁcacy than
the DIOR in the treatment of ISR, demonstrating that DEB with an excipient based
coating are not equally effective. Comparative assessment of DEB in the clinical
setting is warranted.CRT-169
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BACKGROUND Chronic alcohol consumption is known to be a risk factor of signiﬁcant
coronary artery disease (CAD). However, currently there is no available data with
larger study population regarding long-term clinical outcomes of CAS patients (pts)
with chronic alcohol consumption in real world clinical practice.
METHODS A total of 3,349 consecutive pts without signiﬁcant coronary artery disease
(CAD) underwent acetylcholine (Ach) provocation test between Nov. 2004 and May.
2014 and positive CAS pts were enrolled. Signiﬁcant CAS was deﬁned as > 70% of
narrowing by incremental intracoronary injection of 20, 50 and 100 mg into left cor-
onary artery. Patients were divided into two groups based on the presence of alcohol
consumption: the Alcoholic group (n¼1,189), the control group (n¼2,160). To adjust
potential confounders, a propensity score matched (PSM) analysis was performed
using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (877 pairs, n¼1,754, C-
statistic¼0.796) were generated and the baseline characteristics of the two groups
were balanced. At 5 years, there were similar incidence of individual hard endpoints
including mortality, myocardial infarction, revascularization and recurrent angina
requiring repeat coronary angiography between the two groups.
CONCLUSIONS Despite the expected endothelial dysfunction, chronic alcohol con-
sumption was not associated with worse clinical outcomes in CAS pts up to 5 years,
suggesting that the mechanisms and risk factors of CAS may be different from those of
atherosclerotic CAD.CRT-170
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BACKGROUND Ischemic heart diseases including stable angina & acute events,
represent a huge burden on both the individual & the society and represents an
important source of disability.
AIM We aimed to identify the effect of cardiac rehabilitation program (CRP) on the
ischemic burden in patients with ischemic heart disease (IHD) unsuitable for coronary
revascularization.
METHODS Forty patients with IHD who were unﬁt for coronary revascularization were
recruited. All patients were subjected to sophisticated CRP protocols, including patient
